• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDEAVOR RESOLUTE RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number ERES25014X
Device Problems Failure to Advance (2524); Device Dislodged or Dislocated (2923); Physical Resistance/Sticking (4012)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
Event Date 05/06/2018
Event Type  malfunction  
Manufacturer Narrative
Please note that this device (endeavor resolute ) is not marketed in the united states; however, it is similar to the united states marketed product (resolute integrity).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Four endeavor resolute drug-eluting stents were intended to be used to treat a lesion in the mid lad / diagonal branch with severe calcification, severe tortuosity and 90% lesion stenosis.There was no damage noted to packaging.No issues noted when removing the devices from the hoop.The devices were inspected with no issues noted.Negative prep was performed with no issues noted.The devices passed through a previously deployed stent.Resistance was encountered when advancing.The lesion was pre-dilated.The first stent was placed in the anterior descending branch and it was reported that it was unable to pass through the calcified lesion.The stent was removed, further dilation was applied and another stent was used.The second stent also failed to cross the lesion.The third stent became dislodged after failing to cross the lesion.This stent was expanded in situ.The fourth stent was used to support the implanted stent but it was unable to pass the previous stent.This stent was also deployed.The patient is alive with no injury reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Correction: the second stent (2.5x14mm endeavor resolute) dislodged, not the third stent (2.5x30mmendeavor resolute).If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVOR RESOLUTE RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key7761256
MDR Text Key116872345
Report Number9612164-2018-01973
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 10/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/16/2018
Device Catalogue NumberERES25014X
Device Lot Number0008056148
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/24/2018
Date Device Manufactured05/16/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age78 YR
-
-